PI
ARGS

Pharmstandard International’s Argos Therapeutics, Inc. ARGS Stock Holding History

Pharmstandard International’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$83K Hold
826,153
– – 0.29% 6
2018
Q2 		$136K Hold
826,153
– – 0.55% 5
2018
Q1 		$744K Buy
826,153
+169,014
+26% +$316K 1.87% 5
2017
Q4 		$39.4K Sell
657,139
-4,975
-0.8% -$16.7K 40.54% 1
2017
Q3 		$2.38M Hold
662,114
– – 6.93% 4
2017
Q2 		$4.81M Hold
662,114
– – 16.67% 3
2017
Q1 		$5.98M Hold
662,114
– – 15.97% 3
2016
Q4 		$64.9M Buy
+662,114
New +$61.9M 55.88% 1

Pharmstandard International's ARGS Position: Q3 2018 in Review

Pharmstandard International held its Argos Therapeutics, Inc. (ARGS) position steady in Q3 2018 at 826,153 shares worth $83K. The position accounts for 0.29% of the portfolio, ranked #6.

Pharmstandard International first reported a position in ARGS in Q4 2016 and has held it in 8 quarters since. The position peaked at $64.9M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARGS as of Q3 2018.

  • Pharmstandard International held 826,153 shares of Argos Therapeutics, Inc. worth $83K as of Q3 2018.
  • Pharmstandard International left its Argos Therapeutics, Inc. share count unchanged in Q3 2018.
  • Argos Therapeutics, Inc. made up 0.29% of Pharmstandard International's portfolio in Q3 2018, its #6 holding.
  • Pharmstandard International first reported a position in Argos Therapeutics, Inc. in Q4 2016 and has held it in 8 quarters since.
  • Pharmstandard International's Argos Therapeutics, Inc. position peaked at $64.9M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q3 2018.

Based on Pharmstandard International's 13F filing for Q3 2018, filed 15 Nov 2018.